Molecular processes underlying neuromuscular junction denervation in humans with ALS Amyotrophic lateral sclerosis (ALS) is marked by dysfunction and degeneration of neuromuscular junctions (NMJ). Grant type Capacity building grants Area of Research Neurodegeneration Competition ALS Canada - Brain Canada Clinical Research Fellowship 2024 Province Québec Start Date 2024